These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14127691)

  • 1. FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. I. THE EFFECT OF DIET.
    WELLAND FH; HELLMAN ES; GADDIS EM; COLLINS G; HUNTER GW; TSCHUDY DP
    Metabolism; 1964 Mar; 13():232-50. PubMed ID: 14127691
    [No Abstract]   [Full Text] [Related]  

  • 2. FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. II. THE EFFECT OF ETHINYL ESTRADIOL.
    WELLAND FH; HELLMAN ES; COLLINS A; HUNTER GW; TSCHUDY DP
    Metabolism; 1964 Mar; 13():251-8. PubMed ID: 14127692
    [No Abstract]   [Full Text] [Related]  

  • 3. RENAL MECHANISM FOR EXCRETION OF PORPHYRIN PRECURSORS IN PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA AND CHRONIC LEAD POISONING.
    DRUYAN R; HAEGER-ARONSEN B; VON STUDNITZ ; WALDENSTROEM J
    Blood; 1965 Aug; 26():181-9. PubMed ID: 14332480
    [No Abstract]   [Full Text] [Related]  

  • 4. ACUTE INTERMITTENT PORPHYRIA; DIAGNOSIS FOUR YEARS POST MORTEM BY CHEMICAL STUDIES IN RELATIVES.
    THIELE S; WITH TK
    Scand J Clin Lab Invest; 1964; 16():465-9. PubMed ID: 14202026
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effects of glycerol and dextrose on porphyrin precursor excretion in acute intermittent porphyria.
    Bonkowsky HL; Magnussen CR; Collins AR; Doherty JM; Hess RA; Tschudy DP
    Metabolism; 1976 Apr; 25(4):405-14. PubMed ID: 1263834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta-amino-levulinic acid, porphobilinogen, and porphyrin excretion throughout pregnancy in a patient with acute intermittent porphyria with "passive porphyria" in the infant.
    JAMES GW; RUDOLPH SG; ABBOTT LD
    J Lab Clin Med; 1961 Sep; 58():437-44. PubMed ID: 13789298
    [No Abstract]   [Full Text] [Related]  

  • 7. EFFECTS OF CHLOROQUINE ON PATIENTS WITH CUTANEOUS PORPHYRIA OF THE "SYMPTOMATIC" TYPE.
    SWEENEY GD; SAUNDERS SJ; DOWDLE EB; EALES L
    Br Med J; 1965 May; 1(5445):1281-5. PubMed ID: 14278818
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].
    Hocevar V; Rausch-Stroomann JG
    Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556
    [No Abstract]   [Full Text] [Related]  

  • 9. EXPERIMENTAL DISTURBANCE OF PORPHYRIN METABOLISM AND OF LIVER CATALASE ACTIVITY IN GUINEA PIGS AND RABBITS.
    HAEGER-ARONSEN B
    Acta Pharmacol Toxicol (Copenh); 1964; 21():105-15. PubMed ID: 14203041
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of pyridoxine deficiency on porphyrin precursor excretion in acute intermittent porphyria.
    Elder TD; Mengel CE
    Am J Med; 1966 Sep; 41(3):369-74. PubMed ID: 5914112
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of diet in variegate (South African genetic) porphyria.
    Perlroth MG; Tschudy DP; Ratner A; Spaur W; Redeker A
    Metabolism; 1968 Jul; 17(7):571-81. PubMed ID: 5656975
    [No Abstract]   [Full Text] [Related]  

  • 12. EXPERIMENTAL PORPHYRIA IN RATS INDUCED BY CHLORINATED BENZENES.
    RIMINGTON C; ZIEGLER G
    Biochem Pharmacol; 1963 Dec; 12():1387-97. PubMed ID: 14096426
    [No Abstract]   [Full Text] [Related]  

  • 13. PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS.
    TAYLOR JD; PAZDER LH; MARKLE V
    Can Med Assoc J; 1965 Jun; 92(26):1342-4. PubMed ID: 14312444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
    Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EFFECT OF GRISEOFLUVIN IN ACUTE INTERMITTENT PORPHYRIA.
    REDEKER AG; STERLING RE; BRONOW RS
    JAMA; 1964 May; 188():466-8. PubMed ID: 14125225
    [No Abstract]   [Full Text] [Related]  

  • 16. Porphobilinogen and delta-amino levulinic acid in acute porphyria.
    GRANICK S; VANDEN SCHRIECK HG
    Proc Soc Exp Biol Med; 1955 Feb; 88(2):270-3. PubMed ID: 14357411
    [No Abstract]   [Full Text] [Related]  

  • 17. Excretion of porphobilinogen and 5-aminolaevulinic acid in acute porphyria.
    ACKNER B; COOPER JE; GRAY CH; KELLY M; NICHOLSON DC
    Lancet; 1961 Jun; 1(7189):1256-60. PubMed ID: 13681256
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute porphyria. III. The separation of preformed porphyrin and porphobilinogen in the urine in acute porphyria; a coproporphyrin chromogen in normal and pathological urine.
    ERIKSEN L
    Scand J Clin Lab Invest; 1951; 3(2):135-9. PubMed ID: 14854801
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the Waldenström porphyrin of acute porphyria urines.
    NICHOLAS RE; RIMINGTON C
    Biochem J; 1953 Aug; 55(1):109-14. PubMed ID: 13093624
    [No Abstract]   [Full Text] [Related]  

  • 20. Excretion of porphyrins and porphyrin precursors during neuromuscular paralysis produced by dithiobiuret.
    Atchison WD; Peterson RE
    Exp Neurol; 1984 Jul; 85(1):63-8. PubMed ID: 6428932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.